June 27, 2025
A California federal judge on Thursday preliminarily approved Bayer AG’s $38 million settlement with investors who accused the German multinational of downplaying litigation risks related to the weedkiller Roundup when it acquired Monsanto in 2018, saying the deal appeared to be “fair, reasonable and adequate.”
U.S. District Judge Richard Seeborg announced the decision at the end of a hearing held over Zoom, after asking counsel for the investor class how they determined $38 million was an appropriate amount to resolve the lawsuit and confirming the scope of the settlement’s release is confined to the claims of the case.
. . .
Gilden said the case had been “hard fought” and the agreement was an “important settlement and resolution” for their clients.
“After years of litigation and international discovery, this resolution, pending final approval by the court, will help ensure accountability of a foreign company under U.S. securities laws. It will also provide closure for ADR investors harmed by Bayer’s alleged misleading statements,” Gilden said.
The investors are represented by Carol V. Gilden, Steven J. Toll, Christopher Lometti and Benjamin F. Jackson of Cohen Milstein Sellers & Toll PLLC, and Nicole Lavallee and Alexander S. Vahdat of Berman Tabacco.
Read Bayer Investors’ $38M Settlement Over Monsanto Deal OK’d.